Cargando…
Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era
PURPOSE: We aimed to develop and prospectively validate a risk score model to guide individualized concurrent chemoradiotherapy (CCRT) for patients with stage II nasopharyngeal carcinoma (NPC) in intensity‐modulated radiotherapy (IMRT) era. MATERIALS AND METHODS: In total, 1220 patients who received...
Autores principales: | Yang, Shan‐Shan, Pang, Ya‐Jun, Wang, Zhi‐Qiang, Zhang, Bao‐Yu, Liu, Zhi‐Qiao, Chen, En‐Ni, OuYang, Pu‐Yun, Xie, Fang‐Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855903/ https://www.ncbi.nlm.nih.gov/pubmed/34953045 http://dx.doi.org/10.1002/cam4.4520 |
Ejemplares similares
-
Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2022) -
Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis
por: Liu, Zhi-Qiao, et al.
Publicado: (2022) -
Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era
por: Zhang, Lu-Ning, et al.
Publicado: (2015) -
Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis
por: Yang, Shan-Shan, et al.
Publicado: (2021) -
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2021)